Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Co-Designed Digital Education and Peer Support for Young and Middle-Aged Stroke Survivors

21 juillet 2026 mis à jour par: Chang Gung Memorial Hospital

A Co-Designed Digital Education and Peer Support Intervention for Reducing Unmet Needs and Enhancing Recovery Among Young and Middle-Aged Stroke Survivors

Stroke survivors often experience persistent unmet needs during long-term recovery. Young and middle-aged stroke survivors may face additional challenges in balancing rehabilitation with work and family responsibilities. Although digital health interventions have the potential to improve access to education and self-management support, existing programs are often provider-driven, provide limited peer support, and have short follow-up periods.

This study aims to evaluate the effectiveness of a patient-centered digital education and peer support intervention co-designed with young and middle-aged stroke survivors. Participants will be randomly assigned to either the intervention group or the usual care group. The intervention will be delivered through LINE communities and Google collaborative platforms over a 12-month period. The primary outcome is unmet needs. Secondary outcomes include stroke self-efficacy, depressive symptoms, quality of life, activities of daily living, instrumental activities of daily living, and return-to-work status.

Aperçu de l'étude

Description détaillée

Stroke survivors require continuous support to develop healthy lifestyles and self-management behaviors after hospital discharge. However, young and middle-aged stroke survivors often have work and family responsibilities that limit participation in conventional face-to-face education programs. Digital health interventions may improve accessibility and flexibility; however, previous studies have primarily been healthcare provider-led, with limited patient involvement in intervention development, insufficient peer support, relatively short intervention periods, and limited assessment of psychosocial outcomes.

This study consists of two phases. During Phase I, young and middle-aged stroke survivors will participate in a co-design process to develop a patient-centered digital education and peer support intervention. Feedback from a pilot study will be used to refine the intervention before the randomized controlled trial.

During Phase II, eligible participants will be randomly assigned to either the intervention group or the usual care group. Participants in the intervention group will receive a 12-month digital education and peer support program delivered through LINE communities and Google collaborative platforms. The program includes digital educational materials, peer interaction, online meetings, and ongoing support from healthcare professionals. Participants in the control group will receive usual post-stroke care.

Outcome measures will be collected at baseline and at 1, 3, 6, and 12 months after enrollment. The primary outcome is unmet needs. Secondary outcomes include stroke self-efficacy, depressive symptoms, quality of life, activities of daily living, instrumental activities of daily living, and return-to-work status. Longitudinal changes between groups will be analyzed using generalized estimating equations (GEE).

Type d'étude

Interventionnel

Inscription (Estimé)

148

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Aged 31 to 64 years.
  • Diagnosis of stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI) and physician diagnosis.
  • Received treatment at the Stroke Center of Linkou Chang Gung Memorial Hospital.
  • Conscious and able to communicate, including individuals with mild aphasia.
  • Willing and able to provide informed consent.

Exclusion Criteria:

  • End-stage cancer.
  • Severe aphasia resulting in inability to communicate.
  • Dependent in basic activities of daily living before the index stroke (Barthel Index <100), regardless of the underlying cause.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Tripler

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Experimental
Participants will receive a 12-month patient-centered digital education and peer support program
A 12-month patient-centered digital education and peer support program delivered through LINE communities and Google collaborative platforms.
Comparateur actif: Usual Care
Participants will receive usual post-stroke care, including routine follow-up and telephone contacts, without access to the digital education and peer support program.
Routine post-stroke care provided by the participating hospital, including standard discharge education and follow-up telephone contacts.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Unmet Needs
Délai: Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
Assessed using the Unmet Needs Questionnaire for young stroke survivors
Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Self-Efficacy
Délai: Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
Assessed using the Chinese version of the Stroke Self-Efficacy Questionnaire
Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
Depressive Symptoms
Délai: Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
Assessed using the Taiwanese Depression Questionnaire
Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
WHOQOL-BREF Score
Délai: Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
Assessed using the Taiwan version of the WHOQOL-BREF.
Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
Activities of Daily Living
Délai: Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
Assessed using the Barthel Index.
Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
Instrumental Activities of Daily Living
Délai: Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
Assessed using the Lawton Instrumental Activities of Daily Living Scale.
Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
Return-to-Work Status
Délai: 1 month, 3 months, 6 months, and 12 months after enrollment
Assessed using a structured return-to-work questionnaire developed for this study.
1 month, 3 months, 6 months, and 12 months after enrollment

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Wen-Yu Kuo, PhD, Chang Gung University of Science and Technology

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 août 2026

Achèvement primaire (Estimé)

1 juillet 2028

Achèvement de l'étude (Estimé)

1 juillet 2029

Dates d'inscription aux études

Première soumission

21 juillet 2026

Première soumission répondant aux critères de contrôle qualité

21 juillet 2026

Première publication (Réel)

24 juillet 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

24 juillet 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

21 juillet 2026

Dernière vérification

1 juillet 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 202501542A3
  • NSTC 115-2314-B-255-010-MY3 (Autre subvention/numéro de financement: National Science and Technology Council (NSTC), Taiwan)

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner